266 related articles for article (PubMed ID: 7041131)
21. Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.
Doekes G; van Es LA; Daha MR
J Immunol; 1983 Oct; 131(4):1924-9. PubMed ID: 6604753
[TBL] [Abstract][Full Text] [Related]
22. Kinetics of activation of the first component of complement (C1) by IgG oligomers.
Tschopp J
Mol Immunol; 1982 May; 19(5):651-7. PubMed ID: 6287242
[TBL] [Abstract][Full Text] [Related]
23. Solid phase enzyme linked immunosorbent assay for classical complement activation pathway.
Rhen M
J Clin Pathol; 1987 Feb; 40(2):237-9. PubMed ID: 2434532
[No Abstract] [Full Text] [Related]
24. The modulation of immune complex aggregation by classical pathway-mediated reactions.
Gronski P; Bodenbender L; Kanzy EJ; Loos M; Seiler FR
Immunobiology; 1985 May; 169(4):346-61. PubMed ID: 3874147
[TBL] [Abstract][Full Text] [Related]
25. Immunoglobulin-independent utilization of the classical complement pathway in opsonophagocytosis of Escherichia coli by human peripheral leukocytes.
Leist-Welsh P; Bjornson AB
J Immunol; 1982 Jun; 128(6):2643-51. PubMed ID: 6210733
[No Abstract] [Full Text] [Related]
26. Circulating immune complexes in breast cancer patients.
Croce MV; Pasqualini RS; Segal-Eiras A
Medicina (B Aires); 1987; 47(4):371-6. PubMed ID: 3502571
[No Abstract] [Full Text] [Related]
27. Conformational changes in C1q after binding to immune complexes: detection of neoantigens with monoclonal antibodies.
Golan MD; Burger R; Loos M
J Immunol; 1982 Aug; 129(2):445-7. PubMed ID: 6177765
[TBL] [Abstract][Full Text] [Related]
28. Macrophage C1q: characterization of a membrane form of C1q and of multimers of C1q subunits.
Martin H; Heinz HP; Reske K; Loos M
J Immunol; 1987 Jun; 138(11):3863-7. PubMed ID: 3495575
[TBL] [Abstract][Full Text] [Related]
29. Interaction of C1q with beta 2-microglobulin.
Björck L; Johnson U; Sjöholm AG
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():19-23. PubMed ID: 6375255
[TBL] [Abstract][Full Text] [Related]
30. C1 subcomponent complexes: basic and clinical aspects.
Laurell AB; Sjöholm AG
Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
[TBL] [Abstract][Full Text] [Related]
31. Antibody-independent C1 activation by E. coli.
Tenner AJ; Ziccardi RJ; Cooper NR
J Immunol; 1984 Aug; 133(2):886-91. PubMed ID: 6376630
[TBL] [Abstract][Full Text] [Related]
32. The classical complement pathway: activation and regulation of the first complement component.
Cooper NR
Adv Immunol; 1985; 37():151-216. PubMed ID: 3890478
[No Abstract] [Full Text] [Related]
33. The Croonian Lecture, 1980. The complex proteases of the complement system.
Porter RR
Proc R Soc Lond B Biol Sci; 1980 Nov; 210(1181):477-98. PubMed ID: 6110208
[TBL] [Abstract][Full Text] [Related]
34. Kinetics of C1 activation by a monoclonal anti-C1q antibody and its (Fab)2 fragments.
Kilchherr E; Schumaker VN; Bianchino AC; Curtiss LK
J Immunol; 1987 Feb; 138(3):849-55. PubMed ID: 3492535
[TBL] [Abstract][Full Text] [Related]
35. The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the "arms" of C1q.
Hoekzema R; Martens M; Brouwer MC; Hack CE
Mol Immunol; 1988 May; 25(5):485-94. PubMed ID: 3261834
[TBL] [Abstract][Full Text] [Related]
36. [Determination of immunocomplexes. III. A method using a solid surface for immunocomplex binding and use of C1q subcomponent of the first complement component (C1q SP)].
Votruba T; Rákosník P
Cesk Epidemiol Mikrobiol Imunol; 1988 Feb; 37(1):15-22. PubMed ID: 2967114
[No Abstract] [Full Text] [Related]
37. Activation of the first component of complement.
Schumaker VN; Zavodszky P; Poon PH
Annu Rev Immunol; 1987; 5():21-42. PubMed ID: 3036181
[No Abstract] [Full Text] [Related]
38. Activation of the complement system by antibody-antigen complexes: the classical pathway.
Porter RR; Reid KB
Adv Protein Chem; 1979; 33():1-71. PubMed ID: 396780
[No Abstract] [Full Text] [Related]
39. Complement activation and C1q binding activity in haemodialysis.
Dodd NJ; Vergani D; Turney JH; Parsons V; Weston MJ
Proc Eur Dial Transplant Assoc; 1981; 18():300-4. PubMed ID: 6977138
[No Abstract] [Full Text] [Related]
40. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.
Doekes G; van Es LA; Daha MR
Immunology; 1983 Jun; 49(2):215-22. PubMed ID: 6852866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
